F783-0195 Screening compound: N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

F783-0195 Screening compound: N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide
F783-0195 Screening compound: N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F783-0195
N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F783-0195

Molecular Formula

C28H30N4O3 (C28 H30 N4 O3)

Compound Name

N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

IUPAC name

N-{[4-(propan-2-yloxy)phenyl]methyl}-2-[(4-propanamidophenyl)methyl]-1H-13-benzodiazole-5-carboxamide

SMILES

CCC(Nc1ccc(Cc2nc(cc(cc3)C(NCc(cc4)ccc4OC(C)C)=O)c3[nH]2)cc1)=O

InChI

InChI=1S/C28H30N4O3/c1-4-27(33)30-22-10-5-19(6-11-22)15-26-31-24-14-9-21(16-25(24)32-26)28(34)29-17-20-7-12-23(13-8-20)35-18(2)3/h5-14,16,18H,4,15,17H2,1-3H3,(H,29,34)(H,30,33)(H,31,32)

InChI Key

VSLKOFPMKKHWKD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14966699

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.689

Distribution Coefficient, logD

4.687

Water Solubility, LogSw

-4.38

Polar Surface Area

74.614

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

4.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F783-0195 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Epigenetics Focused Set (26518 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with F783-0195 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F783-0195?
Check Price and Availability of F783-0195, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F783-0195 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F783-0195
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F783-0195
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F783-0195 available by request